BioCryst Pharma (BCRX) PT Raised to $28 at Citizens Amid Steady New Patient Starts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 8.26 -0.31 (3.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.57 | 52 Week High | $10.98 | |||
| Open | $8.43 | 52 Week Low | $1.63 | |||
| Day High | $8.86 | P/E | N/A | |||
| Day Low | $8.11 | EPS | $-0.68 | |||
| Volume | 4,691,883 | |||||
